Jump to main content
Jump to site search

Issue 12, 2009
Previous Article Next Article

Inhibition of proteinprotein interactions using designed molecules

Author affiliations

Abstract

Although many cellular processes depend upon enzymatic reactions, proteinprotein interactions (PPIs) mediate a large number of important regulatory pathways and thus play a central role in disease development. In order to understand and selectively inhibit cellular signalling pathways, there is a pressing need for small molecules that target PPIs, particularly in the context of pharmaceutical development. This tutorial review will introduce the relevance of PPIs to chemical biology and highlight the key challenges in designing inhibitors. Some of the successes using conventional approaches to the identification of small-molecule PPI inhibitors will be highlighted, and also the reasons why these approaches have not always proven successful. Several general approaches tailored to particular protein topologies are emerging for the design of scaffolds that inhibit PPIs—these will form the major content of this review. Finally a summary of the challenges to be faced in developing inhibitors of PPIs into drug leads and how these challenges may differ from those encountered with enzyme-like targets will be given.

Graphical abstract: Inhibition of protein–protein interactions using designed molecules

Back to tab navigation

Publication details

The article was received on 30 Apr 2009 and first published on 27 Jul 2009


Article type: Tutorial Review
DOI: 10.1039/B807197G
Citation: Chem. Soc. Rev., 2009,38, 3289-3300
  •   Request permissions

    Inhibition of proteinprotein interactions using designed molecules

    A. J. Wilson, Chem. Soc. Rev., 2009, 38, 3289
    DOI: 10.1039/B807197G

Search articles by author

Spotlight

Advertisements